NIH-funded research NIH-funded research

3D lab-grown model of brain blood vessels to test treatments for subarachnoid hemorrhage

Official title: Development of a 3D neurovascular unit for in vitro modeling of subarachnoid hemorrhage and screening therapies

Funded at Vanderbilt University Medical Center · NIH-11190419 · Data updated 2026-11-12

This project builds a 3D lab model of brain blood vessels to try new therapies that could help people who have subarachnoid hemorrhage (brain bleeding).

More Hemorrhage research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$249,000
NIH project number4R00NS133399-03
Project IDNIH-11190419 on NIH RePORTER

Who could benefit from this research

Could help

People who have experienced subarachnoid hemorrhage or their caregivers who want to follow research progress or potentially donate biological samples in future related studies would be the most relevant audience.

Less likely to help

Patients without subarachnoid hemorrhage or those needing immediate clinical care are unlikely to receive direct benefit from this lab-focused project in the short term.

What this research studies

The team is creating a 3D microfluidic device that mimics the brain's neurovascular unit using biomimetic hydrogels and 3D printing. They will recreate damage like subarachnoid hemorrhage inside the device and expose it to dual-targeted nanoparticles as potential therapies. Experts in vascular biology, neurological disease, and nanoparticle therapeutics will guide the experiments and training. This work is lab-based (in vitro) and is intended to speed up finding promising treatments before animal or human testing.

Why it matters

Potential benefit: If successful, this could help identify treatments more quickly that reduce brain injury and improve recovery after subarachnoid hemorrhage.

How similar studies have gone: Using 3D microfluidic brain models and nanoparticle therapies is an emerging approach with promising early laboratory results but limited clinical proof so far.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: O'grady, Brian J — Vanderbilt University Medical Center
  • Study coordinator: O'grady, Brian J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.